Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu

Code:
3403-v
Name:
Myr-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu
[Myristoyl-PKCζ (113-125)/ζ-Pseudosubstrate Inhibitory Peptide (ZIP)]
Myristoyl-Ser-Ile-Tyr-Arg-Arg-Gly-Ala-Arg-Arg-Trp-Arg-Lys-Leu
(Trifluoroacetate Form)
(M.W. 1928.4) C90H154N30O17
Myristoylated Cell Permeable PKCζ Pseudosubstrate Inhibitor
Package Price(Yen) Availability
Vial 0.5 mg 10,000 Ships within
1-3 business days
Bulk Request

main

Purity:
≧95.0% (HPLC)
Storage:
-20 ℃
Production:
Synthetic Product

Solubility: H2O (1 mM)

more information

Category:
Peptide Tools

reference

  1. C. Laudanna, D. Mochly-Rosen, T. Liron, G. Constantin, and E.C. Butcher, J. Biol. Chem., 273, 30306 (1998). (Pharmacol.)
  2. S. Lim, J.W. Choi, H.S. Kim, Y.-H. Kim, K. Yea, K. Heo, J.H. Kim, S.-H. Kim, M. Song, J.I. Kim, S.H. Ryu, and P.-G. Suh, Life Sci., 82, 733 (2008). (Biochem.)
  3. T. Hirose, D. Satoh, H. Kurihara, C. Kusaka, H. Hirose, K. Akimoto, T. Matsusaka, I. Ichikawa, T. Noda, and S. Ohno, PLoS ONE, 4, e4194 (2009). (Pharmacol. & Histochem.)
  4. P.V. Migues, O. Hardt, D.C. Wu, K. Gamache, T.C. Sacktor, Y.T. Wang, and K. Nader, Nat. Neurosci., 13, 630 (2010). (Pharmacol.)

Documents

PDF SDS:
Japanese / English

Search other product
About Our Product
Technology


Scroll to top